Prebiotic evaluation of red seaweed (Kappaphycus alvarezii) using in vitro colon model

International Journal of Food Sciences and Nutrition

Volumn 68, Issue 7, 2017, Pages 821-828

  Bajury, Dayang Marshitah ^a   Rawi, Muhamad Hanif ^a   Sazali, Iqbal Hakim ^a   Abdullah, Aminah ^b   Sarbini, Shahrul Razid ^a  

^a Universiti Putra   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Bifidobacteria; colon model; gut microbiota; Prebiotic; seaweed

Indexed keywords

INULIN; PREBIOTIC AGENT;

BIFIDOBACTERIUM; BIOLOGICAL MODEL; COLON; FERMENTATION; HUMAN; PHYSIOLOGY; RED ALGA; SEAWEED;

BIFIDOBACTERIUM; COLON; FERMENTATION; HUMANS; INULIN; MODELS, BIOLOGICAL; PREBIOTICS; RHODOPHYTA; SEAWEED;

EID: 85017270424     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2017.1309522     Document Type: Article

References (36)

1. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ., 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 72:3593–3599.
2. Boden G., 2008. Obesity and free fatty acids. Endocrinol Metab Clin North Am. 37:635–646.
3. Bujang JS, Shigeo K., 2012. Historical review of seaweed research in Malaysia before 2001. Coa Mar Sci. 35:169–177.
4. Coles LT, Moughan PJ, Darragh AJ., 2005. In vitro digestion and fermentation methods, including gas production techniques, as applied to nutritive evaluation of foods in the hindgut of humans and other simple-stomached animals. Ani Feed Sci Technol. 123:421–444.
5. Cummings JH, Macfarlane GT., 1991. The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol. 70:443–459.
6. Delattre C, Fenoradosoa TA, Michaud P., 2011. Galactans:an overview of their most important sourcing and applications as natural polysaccharides. Braz Archi Bio Technol. 54:1075–1092.
7. DuBois M, Gilles KA, Hamilton JK, Rebers PAT, Smith F., 1956. Colorimetric method for determination of sugars and related substances. Anal Chem. 28:350–356.
8. Franks AH, Harmsen HJM, Raangs GC, Jansen GJ, Schut F, Welling GW., 1998. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol. 64:3336–3345.
9. Gibson GR, Roberfroid MB., 1995. Dietary modulation of the human colonic microbiota:introducing the concept of prebiotics. J Nutr. 125:1401–1412.
10. Harmsen HJM, Elfferich P, Schut F, Welling GW., 1999. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis. 11:3–12.
11. Hayashi L, Reis RP., 2012. Cultivation of the red algae Kappaphycus alvarezii in Brazil and its pharmacological potential. Rev Bras De Farma. 22:748–752.
12. Hayisama-Ae W, Kantachote D, Bhongsuwan D, Nokkaew U, Chaiyasut C., 2014. A potential synbiotic beverage from fermented red seaweed (Gracilaria fisheri) using Lactobacillus plantarum DW12. Int Food Res J. 21:1789–1796.
13. Kleerebezem M, Vaughan EE., 2009. Probiotic and gut lactobacilli and bifidobacteria:molecular approaches to study diversity and activity. Annu Rev Microbiol. 63:269–290.
14. Kraan S., 2012. Algal polysaccharides, novel applications and outlook. In:Chang PCF, editor. Carbohydrates–comprehensive studies on glycobiology and glycotechnology. Rijeka, Croatia:Intech; p. 489–532.
15. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling GW., 1995. Quantitative fluorescence in situ hybridization of bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol. 61:3069–3075.
16. Louis P, Young P, Holtrop G, Flint HJ., 2010. Diversity of human colonic butyrate86/s12906-015-0802-5" microbial metaboliteslitesbutyryl‐utyrylty of humantransferase gene. Environ Microbiol. 12:304–314.
17. Mandalari G, Faulks RM, Rich GT, Lo Turco V, Picout DR, Lo Curto RB, Bisignano G, Dugo P, Dugo G, Waldron KW. 2008. Release of protein, lipid, and vitamin E from almond seeds during digestion. J Agric Food Chem. 56:3409–3416.
18. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer K-H., 1996. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology. 142:1097–1106.
19. McBurney MI, Thompson LU., 1987. Effect of human faecal inoculum on in vitro fermentation variables. Br J Nutr. 58:233–243.
20. Miller GL., 1959. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem. 31:426–428.
21. Olano-Martin E, Mountzouris KC, Gibson GR, Rastall RA., 2000. In vitro fermentability of dextran, oligodextran and maltodextrin by human gut bacteria. Br J Nutr. 83:247–255.
22. Pokusaeva K, Fitzgerald GF, van Sinderen D., 2011. Carbohydrate metabolism in bifidobacteria. Genes Nutr. 6:285–306.
23. Ranganayaki P, Susmitha S, Vijayaraghavan R., 2014. Study on metabolic compounds of Kappaphycus alvarezii and its in vitro analysis of anti-inflammatory activity. Int J Curr Res Acad Rev. 2:157–166.
24. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzi B, Szajewska H, Stahl B. 2010. Prebiotic effects:metabolic and health benefits. Br J Nutr. 104:S1–S63.
25. Rodrigues D, Walton G, Sousa S, Rocha-Santos TAP, Duarte AC, Freitas AC, Gomes AMP., 2016. In vitro fermentation and prebiotic potential of selected extracts from seaweeds and mushrooms. LWT-Food Sci Technol. 73:131–139.
26. Ruijschop RMAJ, Boelrijk AEM, Te Giffel MC., 2008. Satiety effects of a dairy beverage fermented with propionic acid bacteria. Int Dairy J. 18:945–950.
27. Rumney CJ, Rowland IR., 1992. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr. 31:299–331.
28. Sarbini SR, Kolida S, Naeye T, Einerhart A, Brison Y, Remaud-Simeon M, Monsan P, Gibson GR, Rastall RA. 2011. In vitro fermentation of linear and alpha-1, 2-branched dextrans by the human fecal microbiota. Appl Environ Microbiol. 77:5307–5315.
29. Sarbini SR, Rastall RA., 2011. Prebiotics:metabolism, structure, and function. Food Rev. 3:93–106.
30. Setijawati D, Firdaus M, Kartikaningsih K., 2014. The effect of lactobacillus acidophilus microcapsule which encapsulated by Kappa caragenan toward in vivo functional test. Res J Life Sci. 1:27–36.
31. Slavin J., 2013. Fiber and prebiotics:mechanisms and health benefits. Nutrients. 5:1417–1435.
32. Tobacman J., 2002. Carrageenan in foods:response. Environ Health Pers. 110:A176.
33. Topping DL, Clifton PM., 2001. Short-chain fatty acids and human colonic function:roles of resistant starch and nonstarch polysaccharides. Physio Rev. 81:1031–1064.
34. Vernia P, Caprilli R, Latella G, Barbetti F, Magliocca FM, Cittadini M., 1988. Fecal lactate and ulcerative colitis. Gastroenterology. 95:1564–1568.
35. Zaporozhets TS, Besednova NN, Kuznetsova TA, Zvyagintseva TN, Makarenkova ID, Kryzhanovsky SP, Melnikov VG., 2014. The prebiotic potential of polysaccharides and extracts of seaweeds. Rus J Marine Biol. 40:1–9.
36. Zigová J, Šturdı´k E, Vandák D, Schlosser Š., 1999. Butyric acid production by Clostridium butyricum with integrated extraction and pertraction. Pro Biochem. 34:835–843.